drugset / Trial / NCT03177317
Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy
NaSingle-groupOpen-labelSupportive care
Summary
Feasibility study to evaluate the efficacy of reduced prophylactic dose of dexamethasone in elderly patients receiving moderate emetogenic chemotherapy
Timeline
- Start
- 2017-05-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 6 mg | Intravenous |